Home › Funds › Ranger Investment Management, L.P. › LMAT

Ranger Investment Management, L.P. position in LMAT

LEMAITRE VASCULAR INC · Health Care

Ranger Investment Management, L.P. reported holding 215,502 shares of LMAT (LEMAITRE VASCULAR INC) in its Q3 2026 13F filing — a position valued at US$17.8M, representing 1.67% of its reported portfolio and ranking #18 among its reported holdings. Ranger Investment Management, L.P. has disclosed LMAT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)215.50K sh
Reported value held$17.80M
Portfolio Weight1.67%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Ranger Investment Management, L.P.'s LMAT position evolved

Ranger Investment Management, L.P. first disclosed a stake in LMAT in Q3 2023 at 898,822 shares (US$49.0M). The position peaked in Q2 2024 at 813,913 shares, worth US$67.0M. Across 13 filings, Ranger Investment Management, L.P. increased the stake 1 time(s), trimmed it 11 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 215,502 shares valued at US$17.8M — a reduction of -3,805 shares quarter over quarter.. Notable position changes include a 37% trim in Q1 2026 (shares fell 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 898.82K $48.97M New
Q4 2023 912.50K $51.79M Add
Q1 2024 823.71K $54.66M Reduce
Q2 2024 813.91K $66.97M Reduce
Q3 2024 685.46K $63.67M Reduce
Q4 2024 658.23K $60.65M Reduce
Q1 2025 522.51K $43.84M Reduce
Q2 2025 514.07K $42.69M Reduce
Q3 2025 385.80K $33.76M Reduce
Q4 2025 377.03K $30.58M Reduce
Q1 2026 238.36K $26.02M Reduce
Q2 2026 219.31K $21.04M Reduce
Q3 2026 215.50K $17.80M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LMAT and 13F data

LMAT (LEMAITRE VASCULAR INC) is a Health Care company. 33 other funds we track also report a position in LMAT — the largest reported positions include Copeland Capital Management, LLC (US$76.3M), Conestoga Capital Advisors, LLC (US$72.6M), GENEVA CAPITAL MANAGEMENT LLC (US$42.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LMAT

All LMAT fund holders →

FAQ

How long has Ranger Investment Management, L.P. held LMAT?

Ranger Investment Management, L.P. has disclosed LMAT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Ranger Investment Management, L.P.'s current position in LMAT?

As of Q3 2026, Ranger Investment Management, L.P. holds 215.50K shares of LMAT (LEMAITRE VASCULAR INC), valued at $17.80M, representing 1.67% of its reported portfolio and ranking #18.

Has Ranger Investment Management, L.P. been buying or selling LMAT?

In the latest 13F filing (Q3 2026), Ranger Investment Management, L.P. reduced its position in LMAT. The position peaked in Q2 2024 at 813.91K shares.

Which other funds hold LMAT?

Other major institutional holders of LMAT include Copeland Capital Management, LLC, Conestoga Capital Advisors, LLC, GENEVA CAPITAL MANAGEMENT LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.